Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 USD | +2.93% | -0.40% | -32.25% |
Business Summary
Number of employees: 130
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies and Vaccines
100.0
%
| 45 | 100.0 % | 1 | 100.0 % | -98.21% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom and United States
100.0
%
| 45 | 100.0 % | 1 | 100.0 % | -98.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Enright
CEO | Chief Executive Officer | 61 | 19-07-31 |
Gemma Brown
DFI | Director of Finance/CFO | 34 | 21-08-31 |
Nadège Pelletier
CTO | Chief Tech/Sci/R&D Officer | 46 | 23-01-31 |
Investor Relations Contact | - | 22-09-30 | |
Graham Griffiths
PRN | Corporate Officer/Principal | 45 | 17-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 21-02-28 |
William Enright
CEO | Chief Executive Officer | 61 | 19-07-31 |
Anne Phillips
BRD | Director/Board Member | 70 | 21-02-20 |
Robin Wright
CHM | Chairman | 59 | 18-09-30 |
Director/Board Member | 61 | 17-12-31 | |
Alex Hammacher
BRD | Director/Board Member | 43 | 19-12-31 |
Joseph Scheeren
BRD | Director/Board Member | 68 | 21-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,643,540 | 37,217,593 ( 96.31 %) | 0 | 47.98 % |
Stock B | 1 | 38,921,212 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.25% | 97.3M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BRNS Stock
- Company Barinthus Biotherapeutics plc